BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Biotech Bay

  Amyris, Inc. to Participate in Investor Conferences

  March 30, 2012

   · 

  1 min read
• Policy

  US District Court Finds AstraZeneca PLC’s SEROQUEL XR Formulation Patent Valid and Infringed

  March 30, 2012

   · 

  1 min read
• Genetown

  ImmunoGen, Inc. Announces Conference Call at 8:00 am ET March 30, 2012 to Discuss Today’s Favorable Announcements about Trastuzumab Emtansine (T-DM1) and About IMGN901

  March 30, 2012

   · 

  1 min read
• Business

  Artimplant Publishes the Annual Report of 2011

  March 30, 2012

   · 

  1 min read
• Business

  Swedish Orphan Biovitrum Amends its Agreement With Sellers of Arexis AB

  March 30, 2012

   · 

  2 min read
• Australian Drug Developer, Hunter Immunology Limited, Set to List on ASX

  March 30, 2012

   · 

  1 min read
• Policy

  Threshold Pharmaceuticals, Inc.'s Cancer Drug Gets FDA Orphan Status, Shares Rise

  March 30, 2012

   · 

  1 min read
• Business

  Bio-Path Holdings, Inc. Engages PondelWilkinson for Retail Investor Relations Program

  March 30, 2012

   · 

  1 min read
• Drug Development

  ImmunoGen, Inc. Announces Initiation of Phase II Evaluation of Its IMGN901 Product Candidate

  March 30, 2012

   · 

  4 min read
• Pharm Country

  Robard Corporation Release: Dr. Robert F. Kushner to Speak at Annual Conference on Obesity Treatment in Primary Care

  March 30, 2012

   · 

  2 min read